Charles Schwab Investment Management Inc Infinity Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $100,593 - $246,350	-205,292 Reduced 87.27%	29,948 $19,000
Q1 2022 May 13, 2022	BUY	$0.85 - $2.4 $16,821 - $47,496	19,790 Added 9.19%	235,240 $269,000
Q3 2021 Nov 16, 2021	SELL	$1.52 - $3.82 $185 - $466	-122 Reduced 0.06%	215,450 $737,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $493,759 - $644,115	185,624 Added 619.82%	215,572 $645,000
Q1 2019 May 14, 2019	BUY	$1.18 - $1.91 $35,338 - $57,200	29,948 New	29,948 $57,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.